Scientific consensus for family planning in patients with multiple sclerosis

Scientific consensus for family planning in patients with multiple sclerosis

More than forty neurologists participate in a scientific consensus document for the planning of patients with multiple sclerosis (ConPlanEM), a project whose objective is to serve as a reference for professionals, improving care in the fertile age of this neurological disease.

This consensus document, which will be known in the first months of 2022, has been announced by the executive president of the Merck Salud Foundation, Carmen González Madrid, during the award ceremony for the VI Solidarity Awards with Multiple Sclerosis, promoted by this foundation, with the endorsement of the Española de Neurología (SEN).

Currently, she has added, "in the pharmacological approach of patients with multiple sclerosis of childbearing age there is a variability of criteria between professionals, centers and autonomous communities that generates differences in decision-making".

Personalized treatments, research into biomarkers and early evaluation of diagnoses are the way so that "one day we will be able to cure this disease", said the president of the Merck Health Foundation.

The news of multiple sclerosis, three experts speak

In the course of this meeting, three experts have analyzed the actuality of this pathology.

They have been María Teresa Marín, General Director of Humanization and Socio-Sanitary Assistance of Castilla-La Mancha; biologist Diego Clemente López, director of the Neuroimmuno-Repair Laboratory of the National Hospital for Paraplegics in Toledo; and Asier de la Iglesia, basketball player, multiple sclerosis patient and founder of the Baila con EM Association.

to the day as there was this great #garagesale by #YodaPress. And I was meeting an ass of a person, who managed my… https://t.co/HCBwSfvejm

— Saurabh (He / Him / His from him) 🏳‍🌈🌈 Sat Mar 13 15:33:36 +0000 2021

In this debate, the speakers have made it clear that research, knowledge, collaboration and humanization are key to addressing the future of MS, a disease that generally begins to manifest itself in people between 20 and 40 years of age, which makes it the most common neurological disease in young adults and the most common non-traumatic disabling neurological disorder in this age range.

María Teresa Marín has recognized the impact that the pandemic has had on the health system when it comes to caring for patients with multiple sclerosis, but also the trust that has been generated in scientific research and, in the case of MS, « turning this pathology, more and more, into a chronic ailment ».

For his part, Diego Clemente López has emphasized the need to advance in the understanding of the causes of this pathology in order to predict the future and achieve greater collaboration between basic and clinical research.

“When the origin of this disease is known, more specific treatments can be found to try to stop multiple sclerosis“, a disease that, he recalled, is as heterogeneous as it is unpredictable, and in which various treatments are handled because each patient is a world.

Asier de la Iglesia has emphasized the need for greater knowledge of multiple sclerosis by society and the business world, in order, among other things, to facilitate patients' access to the world of work, because they can work perfectly .

Some facts about multiple sclerosis

Multiple sclerosis is a chronic and degenerative neurological disease that mainly affects women, three out of four cases.

In Spain, some 2,000 new cases are diagnosed each year, 70 percent of them in people between 20 and 40 years old, according to SEN data.

Solidarity prizes with MS

The awards given in this sixth edition aim to contribute to the normalization of this disease and give it maximum visibility.

These are the six projects awarded by the Merck Salud Foundation.

collective category

single category